According to Incyte's latest financial reports the company's current earnings (TTM) are $1.01 B. In 2022 the company made an earning of $0.52 B a decrease over its 2021 earnings that were of $0.57 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.83 B | 57.66% |
2022 | $0.52 B | -7.24% |
2021 | $0.57 B | -345.65% |
2020 | -$0.24 B | -147.7% |
2019 | $0.48 B | 322.02% |
2018 | $0.11 B | -136.94% |
2017 | -$0.32 B | -390.76% |
2016 | $0.10 B | 1322% |
2015 | $7.55 M | -115.56% |
2014 | -$48.55 M | -41.4% |
2013 | -$82.85 M | 87.67% |
2012 | -$44.15 M | -74.9% |
2011 | -$0.18 B | 843.59% |
2010 | -$18.64 M | -88.68% |
2009 | -$0.17 B | 1.37% |
2008 | -$0.17 B | 86.16% |
2007 | -$87.26 M | 17.64% |
2006 | -$74.17 M | -28.62% |
2005 | -$0.11 B | -36.1% |
2004 | -$0.17 B | -2.03% |
2003 | -$0.17 B | 22.26% |
2002 | -$0.14 B | -27.39% |
2001 | -$0.19 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Novartis NVS | $9.82 B | 864.83% | ๐จ๐ญ Switzerland |
Pfizer PFE | $3.26 B | 220.76% | ๐บ๐ธ USA |
Eli Lilly LLY | $7.56 B | 642.35% | ๐บ๐ธ USA |
Amgen AMGN | $7.85 B | 671.22% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $64.31 M | -93.69% | ๐บ๐ธ USA |
Geron GERN | -$0.18 B | -117.26% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | -$69.24 M | -106.80% | ๐บ๐ธ USA |
AVEO Oncology
AVEO | -$29.04 M | -102.85% | ๐บ๐ธ USA |
Ardelyx ARDX | -$65.52 M | -106.43% | ๐บ๐ธ USA |